15th Tumour Models Summit London
December 2, 2026 - GBHanson Wade
info@hansonwade.com
Phone:+16174554188
The 15th Tumour Models Summit London is Europe's longest-standing and most comprehensive meeting dedicated to advancing preclinical and translational tumour modelling. As oncology pipelines become increasingly dependent on immunotherapies, cell therapies, ADCs, radioligand therapies, and precision medicines, development teams face growing pressure to improve translational confidence, identify predictive models, and generate decision-grade evidence earlier in development. Join leaders from Roche, AstraZeneca, Johnson and Johnson, Eli Lilly, Immunocore, Merck, Molecular Partners, ImmunoKey, and innovative oncology biotechs to explore how human-relevant models, NAMs, AI-enabled approaches, patient-derived systems, biomarkers, tumour microenvironment models, and integrated development strategies can improve candidate selection, predict clinical outcomes, and reduce late-stage attrition. Whether your focus is model validation, safety prediction, tumour microenvironment biology, translational biomarkers, AI-driven prediction, or regulatory strategy, this is the industry's definitive forum for improving oncology model translatability. Time: 8:05 am to 3:40 pm